DERM
$8.09
Dermira
DERM
Earnings Whisper ®
N/A
4th Quarter December 2019
Consensus:  ($1.34)
Revenue:  $12.65 Mil
Tuesday
Feb 4
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when DERM reports earnings?
Beat
Meet
Miss

Where is DERM's stock price going from here?
Up
Flat
Down
Stock chart of DERM
Analysts
Summary of analysts' recommendations for DERM
Score
Grade
Pivots
Resistance
$8.77
$8.55
$8.32

$8.10

Support
$7.87
$7.65
$7.42
Tweet
Growth
Peers
BioMarin PharmaceuticalRegeneron PharmaceuticalsVertex PharmaceuticalsCelgeneInterCeptJohnson & JohnsonMylanZoetisEndo International plcUltragenyx Pharmaceutical